Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Clinical Trial Imaging Market Growth Performance Trended Historically, And What Lies Ahead?

In the past few years, the clinical trial imaging market has seen significant expansion. The market size, which stands at $1.44 billion in 2024, is projected to escalate to $1.58 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. The historical growth has been driven by factors such as improved sales and distribution of clinical imaging software and services, a heightened risk of breast cancer, higher healthcare spending that leads to better infrastructure, as well as increased investment in research and development by pharmaceutical and biotechnological firms.

What Is the Forecast for the Clinical Trial Imaging Market Size Through 2029?

Expectations indicate a significant surge in the clinical trial imaging market size within the upcoming years. The market is projected to expand to a staggering $2.26 billion in 2029, with a compound annual growth rate (CAGR) of 9.3%. This expected growth in the forecast period can be traced back to factors such as the escalating prevalence of chronic diseases, surging research and development spending, expanding older population, increasing clinical studies, and the rise of contract research organizations. Key trends during the forecasted period involve technological progress improving imaging modalities, strategic steps taken by market key players to broaden their capabilities and offerings, implementation of imaging-based techniques in drug innovation, advancements in molecular imaging alongside AI-driven analysis, and product innovation.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15765&type=smp

What are the Key Market Players in Clinical Trial Imaging Market and How They’re Evolving?

Major companies operating in the clinical trial imaging market are Koninklijke Philips N.V., Labcorp Drug Development, Icon Plc, PPD Inc., Syneos Health, Charles River Laboratories, Parexel International Corporation, Clario, Medpace Inc., Medidata Solution Inc., Biotelemetry Inc., WIRB-Copernicus Group, ProScan Imaging LLC, Invicro LLC, Perspectum, Radiant Sage LLC, Worldcare Clinical LLC, Intrinsic Imaging LLC, Datatrak Inc., IXICO Plc, Calyx Inc., Resonance Health Ltd., Anagram-ESIC SL

What Are the Primary Growth Drivers in the Clinical Trial Imaging Market?

The rising occurrence of chronic illnesses is anticipated to boost the expansion of the clinical trial imaging market. Chronic disease is a condition that typically lasts for a significant period, often necessitating continuous medical care, and can restrict daily tasks or diminish the quality of life. This increasing occurrence can be attributed to factors such as exposure to air pollution, chemicals and toxins, lifestyle alterations, and genetics. Clinical trial imaging offers effective oversight through imaging, which enables patients to grasp their situation and the ramifications of treatment, thus enhancing compliance and fulfilment. For example, the National Center for Biotechnology Information (NCBI), a National Library of Medicine based in the US, forecasted in January 2023 that by 2050, the population of individuals aged 50 or older who are suffering from at least one chronic disease will skyrocket by 99.5%, increasing from 71.522 million in 2020 to 142.66 million. Consequently, the rising prevalence of chronic diseases is a driving force for the clinical trial imaging market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15765&type=smp

What Are the Leading Segments in the Global Clinical Trial Imaging Industry?

The clinical trial imaging market covered in this report is segmented –

1) By Product And Services: Services, Software

2) By Modality: Computed Tomography, Magnetic Resonance Imaging, Echocardiography, Nuclear Medicine, Positron Emission Tomography, X-Ray, Ultrasound, Optical Coherence Tomography, Other Modalities

3) By Application: Oncology, Neurology, Cardiology, Endocrinology, Dermatology, Hematology, Other Applications

4) By Distributer: Direct Sales, Tender Sales

5) By End User: Contract Research Organizations, Pharmaceutical And Biotechnology Companies, Medical Device Manufacturers, Academic And Government Research Institutes, Other End-Users

Subsegments:

1) By Services: Imaging Services For Diagnostics, Image Acquisition Services, Image Analysis Services, Image Management And Archiving Services

2) By Software: Imaging Software For Analysis, Image Processing Software, Radiology Information Systems (RIS), Picture Archiving And Communication Systems (PACS)

What Are the Key Market Trends in the Clinical Trial Imaging Industry?

Key players in the clinical trial imaging market are introducing cloud-based image tools with an intent to offer superior solutions and enhance the proficiency of clinical trials. These cloud-based imaging tools are software systems and platforms that employ cloud computing technology to save, maintain and scrutinize medical images. As an instance, Clarion, a US-based manufacturer of sophisticated power distribution systems, released an avant-garde cloud-based image viewer tool in March 2023. This pioneering tool provides real-time, on-demand observation and modification of high-resolution images, leading to read-quality access to images almost instantly while removing the need for previously necessary manual steps. It refines the process of image viewing by getting rid of manual steps and ensuring the simplicity, security, and data privacy compliance of image accessibility. The tool presents full-resolution viewing and modification features, enabling end users to acquire significant understanding about their trial subject.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/clinical-trial-imaging-global-market-report

What Is the Regional Outlook for the Clinical Trial Imaging Market?

North America was the largest region in the clinical trial imaging market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15765

This Report Delivers Insight On:

1. How big is the clinical trial imaging market, and how is it changing globally?

2. Who are the major companies in the clinical trial imaging market, and how are they performing?

3. What are the key opportunities and risks in the clinical trial imaging market right now?

4. Which products or customer segments are growing the most in the clinical trial imaging market?

5. What factors are helping or slowing down the growth of the clinical trial imaging market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model